国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 6月6日

China IM Obesity Search & Evaluation & CI Lead

9-12萬
  • 上海靜安區(qū)
  • 5-10年
  • 碩士
  • 全職
  • 招1人

雇員點評標簽

  • 同事很nice
  • 團隊執(zhí)行強
  • 工作環(huán)境好
  • 人際關(guān)系好
  • 氛圍活躍
  • 實力大公司

職位描述

藥企
ROLE SUMMARY China Internal Medicine (IM) Search and Evaluation (S&E) Lead is a key role in supporting the China Business Development needs. This role is the external face of Pfizer in China for the Internal Medicine & Obesity therapeutic areas, and will foster a broad network throughout the Biotech / Pharmaceutical industry in China. The focus of this role is on sourcing and assessing preclinical/post-CAN compounds, early clinical development stage (Phase 1 and 2) opportunities, as well as later stage and commercial opportunities. Key aspects of this role include contributing to therapeutic area strategy development; ensuring proactive, targeted search activities are undertaken on mechanisms and indications of strategic interest; establishing and maintaining relationships with the Internal Medicine & Obesity biotech / biopharma community in China; leading multidisciplinary teams to efficiently and thoroughly assess external opportunities. For transactional stage opportunities, this role supports deal execution as a deal team member and provides inputs on deal-structuring and contract negotiations, leveraging the existing working relationships with the potential partners. ROLE RESPONSIBILITIES ● Contributes to Internal Medicine & Obesity strategy development and executes the BD component of the strategy, in partnership with the WWBD Internal Medicine & Obesity S&E colleagues ● Accountable for covering the external landscape such that external opportunities are proactively sourced, thoroughly evaluated, prioritized and brought forward to governance for decision. ● Identifies relevant companies (based on scientific or other capabilities) and ensures that strong relationships are established and maintained in areas of interest to Pfizer Internal Medicine & Obesity ● Serves as primary point of contact with the potential partner prior to submission of non-binding term sheet and thereafter partners in this role with Transactional lead ● Together with Transactional lead, coordinates preparation and presentation of materials for senior management briefings ● Supports cross-Category assessments, Pfizer Ventures / China Investment Vehicle opportunities evaluations, and out-licensing projects as needed ● Support the identification and evaluation of late stage and commercial opportunities for China or International markets ● Acts as liaison to Integration/Alliance Management in immediate post-deal completion period ● Support relevant management dashboards / presentations BASIC QUALIFICATIONS ● To understand the scientific, regulatory and commercial issues associated with the evaluation of external opportunities, this role is expected to have a strong scientific background (PhD or MD) and extensive drug development knowledge ● Search and Evaluation experience with clinical stage assets is preferred ● Excellent communication, influencing, and interpersonal skills; the role involves extensive interactions with senior management both within Pfizer and with potential partner companies ● Strong project management skills with broad experience in leading multidisciplinary teams (e.g. interacts with wide range of colleagues from Discovery scientists to in-line product team members) ● Experience in management consulting / investment is preferred ● Extensive therapeutic area network throughout the China Biotech/Pharma industry NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS ● ~25% travel is anticipated ● For a given project, it may be necessary to work at night or over the weekend to meet a deadline Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Bus Dev & Strategic Planning #LI-PFE

工作地點

上海靜安區(qū)中信泰富廣場

職位發(fā)布者

劉一飛/人事經(jīng)理

當(dāng)前在線
立即溝通
公司Logo輝瑞投資有限公司公司標簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學(xué)和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過程中,輝瑞始終致力于奉行嚴格的質(zhì)量、安全和價值標準。我們在全球的產(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達和新興市場的員工都在推進人類健康,推動疾病的預(yù)防、治療和治愈,以應(yīng)對挑戰(zhàn)我們這個時代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責(zé)任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時代,成為一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務(wù)覆蓋全國300余個城市,累計投資超過15億美元,并設(shè)立了1家先進的生產(chǎn)設(shè)施,2個研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個領(lǐng)域的處方藥和疫苗,強大完善的產(chǎn)品線旨在滿足生命各階段的健康需求。
公司主頁